> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-12/
- Published: 2020-02-17T12:00:00.000Z
- Updated: 2026-09-14T16:03:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146116

[**Comments Extended on Combo Product Bridging Guide**](https://www.fdaweb.com/comments-extended-on-combo-product-bridging-guide/)  
*Federal Register* notice: FDA extends until 4/20 the comment period for a 12/2019 draft guidance on Bridging for Drug-Device and Biologic-Device Combination Products. 02/14/2020  

[**28 ‘No Longer Marketed’ ANDAs Withdrawn** ](https://www.fdaweb.com/28-no-longer-marketed-andas-withdrawn/)*Federal Register* notice: FDA withdraws approval of 28 ANDAs from multiple applicants. 02/14/2020  

[**Guide on Peripheral Vascular Atherectomy Device PMAs**](https://www.fdaweb.com/guide-on-peripheral-vascular-atherectomy-device-pmas/)  
*Federal Register* notice: FDA posts a final guidance entitled “Peripheral Vascular Atherectomy Devices — Premarket Notification Submissions.” 02/13/2020  

[**FDA Seeks Nonvoting Patient Engagement Panel Members**](https://www.fdaweb.com/fda-seeks-nonvoting-patient-engagement-panel-members/)  
*Federal Register* notice: FDA seeks industry organizations interested in participating in selecting nonvoting industry representatives to serve as temporary nonvoting members on CDRH’s Patient Engagement Advisory Committee. 02/13/2020  

[**Info Collection on Rapid Response Surveys**](https://www.fdaweb.com/info-collection-on-rapid-response-surveys/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “FDA Rapid Response Surveys.” 02/12/2020  

[**Meeting on Drug Development for Vitiligo**](https://www.fdaweb.com/meeting-on-drug-development-for-vitiligo/)  
*Federal Register* notice: FDA announces a 3/30 public meeting entitled “Patient-Focused Drug Development for Vitiligo.” 02/11/2020  

[**Info Collection on Device Risk Allegations**](https://www.fdaweb.com/info-collection-on-device-risk-allegations/)  
*Federal Register* notice: FDA seeks comments on an information collection entitled “Electronic Submission Process for Voluntary Allegations to the Center for Devices and Radiological Health.” 02/10/2020